Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Sing George L sold 21,129 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Sing George L (Director) sold 21,129 Regeneron Pharmaceuticals, Inc. shares at an average US$964.38 for US$20.4M, leaving 25,147 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 21,129 shares
- Price
- US$964.38 average (US$960.57 to US$970.18)
- Value
- US$20.4M
- Holding after
- 25,147 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Option exercise | 7,830 | US$376.69 | 38,837 | Direct |
| Nov 2, 2026 | Common Stock | Option exercise | 7,439 | US$380.95 | 46,276 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,224 | US$960.57 | 45,052 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 540 | US$961.85 | 44,512 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 2,522 | US$962.61 | 41,990 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 4,338 | US$963.47 | 37,652 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 2,670 | US$964.57 | 34,982 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 7,073 | US$965.38 | 27,909 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,522 | US$966.27 | 26,387 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,040 | US$967.07 | 25,347 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 200 | US$970.18 | 25,147 | Direct |
Source
Download original · View original at SEC
Related
- Regeneron Pharmaceuticals, Inc.
- Sing George L
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Sing George L · Nov 18, 2026
- Form 4 · Murphy Andrew J · Nov 18, 2026
- Form 4 · McCourt Marion · Nov 18, 2026
- Form 4 · Pitofsky Jason · Nov 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026